Defiance Daily Target 2X Long NVO ETF(NVOX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

NVOX Defiance Daily Target 2X Long NVO ETF

Pre-Mkt 07-06 04:33:38 EDT

17.75

+1.11

+6.67%

盘前17.43

-0.32-1.80%

04:30 EDT

High18.04	Low17.33	Vol359.18K
Open17.33	D1 Closing16.64	Amplitude4.28%
Mkt Cap55.17M	Tradable Cap55.17M	Total Shares3.11M
T/O6.36M	T/O Rate11.56%	Tradable Shares3.11M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"NVOX","market":"US","secType":"STK","nameCN":"Defiance Daily Target 2X Long NVO ETF","latestPrice":17.75,"timestamp":1783022400000,"preClose":16.64,"halted":0,"volume":359178,"hourTrading":{"tag":"盘前","latestPrice":17.43,"preClose":17.75,"latestTime":"04:30 EDT","volume":1330,"amount":23080.350509999997,"timestamp":1783326613088,"change":-0.32,"changeRate":-0.018028,"amplitude":0.024225},"delay":0,"changeRate":0.06670673076923073,"floatShares":3108101,"shares":3108101,"eps":0,"marketStatus":"Pre-Mkt","change":1.11,"latestTime":"07-06 04:33:38 EDT","open":17.33,"high":18.0425,"low":17.33,"amount":6361531.939614,"amplitude":0.042819,"askPrice":17.46,"askSize":1750,"bidPrice":17.39,"bidSize":1300,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1783344600000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":17.75,"sharesOutstanding":4098101,"nav":17.73,"aum":55106630.73,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":17.43,"preClose":17.75,"latestTime":"04:30 EDT","volume":1330,"amount":23080.350509999997,"timestamp":1783326613088,"change":-0.32,"changeRate":-0.018028,"amplitude":0.024225},"postHourTrading":{"tag":"盘后","latestPrice":17.71,"preClose":17.75,"latestTime":"19:15 EDT","volume":1796,"amount":31666.78,"timestamp":1783034107049,"change":-0.04,"changeRate":-0.002254,"amplitude":0.008451},"volumeRatio":0.9487666339406076,"impliedVol":0.7804,"impliedVolPercentile":0.3012},"requestUrl":"/m/hq/s/NVOX/tweets","defaultTab":"tweets","newsList":[{"id":"1111335248","title":"Trump’s FDA May Soon Throw Its Weight Behind Peptides. Should You Buy In?","url":"https://stock-news.laohu8.com/highlight/detail?id=1111335248","media":"Macro World","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111335248?lang=en_us&edition=fundamental","pubTime":"2026-07-06 11:39","pubTimestamp":1783309194,"startTime":"0","endTime":"0","summary":"","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"37c8d9de4cc74b718092c554f88a5cc4","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LLY","NVOH","PFE","RHHBY","LLYZ","LLII","ELIS","LLYX","NVO","VKTX","AMGN","NVOX","GPCR","ELIL"],"isVideo":true,"video":{"duration":74,"video_url":"https://1254107296.vod2.myqcloud.com/e2ad4227vodcq1254107296/9044a4515001834810501024972/MWrOTca1gokA.mp4","video_thumbnail":"https://community-static.tradeup.com/news/42e81e07ef6b910080850b2d9b343c60"},"gpt_icon":0},{"id":"2649690202","title":"Trump's FDA May Soon Throw Its Weight Behind Peptides. Should You Buy In?","url":"https://stock-news.laohu8.com/highlight/detail?id=2649690202","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649690202?lang=en_us&edition=fundamental","pubTime":"2026-07-05 14:00","pubTimestamp":1783231200,"startTime":"0","endTime":"0","summary":"Many Americans would love a drug that makes them fitter, sharper, and more attractive. The peptides industry aims to oblige, and sales may soon be off to the races, courtesy of the Trump Administratio","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","HMYY","IE00BKVL7J92.USD","PPH","HIMZ","HEAL","LU0154236417.USD","HIYY","OZEM","THNR","BK4599","BK4196","IE00BZ1G4Q59.USD","HIMS","BK4588","LU1093756325.SGD","BK4007","LU1093756168.USD","NVOX","NVO","BK4532","HIMY","NVOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648937836","title":"Novo Nordisk (NVO) Wins UK Wegovy Pill Approval As Medicare Opens GLP 1 Access","url":"https://stock-news.laohu8.com/highlight/detail?id=2648937836","media":"Simply Wall St.","labels":["productRelease","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648937836?lang=en_us&edition=fundamental","pubTime":"2026-07-04 06:33","pubTimestamp":1783117982,"startTime":"0","endTime":"0","summary":"Novo Nordisk received major UK regulatory approval for its GLP-1 weight-loss pill version of Wegovy.\nThe U.S. Medicare program began covering the company’s GLP-1 injections for eligible patients.\nNovo Nordisk launched supplier cost-efficiency measures to respond to rising competition in GLP-1 treatments.\n\nNovo Nordisk (NYSE:NVO) is in focus after fresh approvals and reimbursement decisions related to its GLP-1 weight-loss treatments. The stock last closed at $50.43, with the share price up...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nvo/novo-nordisk/news/novo-nordisk-nvo-wins-uk-wegovy-pill-approval-as-medicare-op","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nvo/novo-nordisk/news/novo-nordisk-nvo-wins-uk-wegovy-pill-approval-as-medicare-op","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0154236417.USD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","NVOH","BK4007","PPH","LU1093756168.USD","BK4585","BK4599","BK4532","OZEM","LU1093756325.SGD","NVOX","THNR","NVO","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648662342","title":"Novo Nordisk A/S Stock Falls Friday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2648662342","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648662342?lang=en_us&edition=fundamental","pubTime":"2026-07-04 00:02","pubTimestamp":1783094520,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S slid 1.5% to DKK326.90 Friday on what proved to be an overall positive trading session for the stock market, with the OMX Nordic 40 Index rising 0.9% to 2,758.19.The stock's fall  snapped a two-day winning streak.The company closed DKK137.70 below its 52-week high of DKK464.60, which the company reached on July 28, 2025.Trading volume was 2,575,490, compared to the 50-day average trading volume of 5,675,033.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 03, 2026 12:02 ET Copyright  2026 Dow Jones & Company, Inc.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OZEM","BK4007","NVOX","NVO","PPH","IE00BKVL7J92.USD","BK4532","THNR","LU1093756168.USD","LU1093756325.SGD","BK4588","LU0154236417.USD","BK4599","BK4585","NVOH","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648501885","title":"Novo Nordisk Reportedly Seeks Lower Prices From Suppliers to Stay Competitive","url":"https://stock-news.laohu8.com/highlight/detail?id=2648501885","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648501885?lang=en_us&edition=fundamental","pubTime":"2026-07-02 18:37","pubTimestamp":1782988648,"startTime":"0","endTime":"0","summary":"Novo Nordisk  is seeking lower prices from suppliers to lower its own expenses to remain competitive with rivals in the weight-loss drug market, news outlets reported Thursday.Bloomberg cited a statement from the company that it was seeking lower raw materials costs in order to compete commercially.The Danish news outlet Finans, which first reported the news, said the suppliers were told if they didn't comply it could hut future deals.Novo Nordisk did not immediately reply to MT Newswires' request for comment.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","LU1093756325.SGD","NVOH","NVO","BK4588","BK4599","LU1093756168.USD","IE00BZ1G4Q59.USD","BK4007","BK4585","NVOX","LU0154236417.USD","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648055475","title":"Why Medicare Isn't a Game Changer for Weight-loss Drugmakers","url":"https://stock-news.laohu8.com/highlight/detail?id=2648055475","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648055475?lang=en_us&edition=fundamental","pubTime":"2026-07-02 17:30","pubTimestamp":1782984600,"startTime":"0","endTime":"0","summary":"Medicare began covering weight-loss drugs for seniors this week. For patients long shut out from the GLP-1 boom, the opening is a real milestone. For Wall Street, it isn't the immediate windfall the h","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELIL","LU2168564222.USD","LU1366192091.USD","LU1989771016.USD","SG9999001176.USD","GB00BDT5M118.USD","LU2168563687.JPY","LU0266013472.USD","IE0009355771.USD","LU0203202063.USD","NVOX","LU1917777945.USD","LU2106854487.HKD","LU0353189680.USD","LU0114720955.EUR","LU0316494557.USD","LU2471134796.USD","IE0005OL40V9.USD","LU0823434740.USD","LU0466842654.USD","LU0154236417.USD","LU0109394709.USD","LU1720051108.HKD","LU2168564065.EUR","ELIS","LU1720051017.SGD","LU0158827948.USD","IE00BKVL7J92.USD","IE00BFSS8Q28.SGD","SG9999018865.SGD","LU2265009873.SGD","LU2089283258.USD","LU2471134523.USD","IE00B775H168.HKD","IE00B4R5TH58.HKD","LU1868836757.USD","LU2023251221.USD","LU0158827781.USD","LU2746668461.USD","LU1868836914.USD","LU2462157665.USD","IE00B1BXHZ80.USD","LU1127390331.HKD","LU1057294990.SGD","LU1551013425.SGD","LU2461242641.AUD","IE0001KFT4U8.USD","IE0004445239.USD","LU0238689110.USD","LU2750360997.AUD","SG9999014898.SGD","LLY","LU0354030511.USD","LU0456855351.SGD","LU0354030438.USD","LU1548497426.USD","SG9999015986.USD","LU0889565916.HKD","IE00B4JS1V06.HKD","LU0097036916.USD","LU0234572021.USD","SG9999014914.USD","IE0004445015.USD","LU2023250504.SGD","BK4599","LU2491050071.SGD","LU2168564149.EUR","SGXZ99366536.SGD","SG9999018857.SGD","LU2456880835.USD","SGXZ57979304.SGD","LU0006306889.USD","LU2111349929.HKD","LU1061106388.HKD","LU2552382058.USD","LU2552382132.HKD","LU0256863902.USD","LU0823416689.USD","LU1323610961.USD","LU1974910355.USD","LU2168564495.EUR","IE00B1XK9C88.USD","LU0640476718.USD","BK4581","LU0079474960.USD","LU2491049909.HKD","LU0094547139.USD","LU2112291526.USD","LU1983299246.USD","SGXZ51526630.SGD","LU2361045086.USD","LU1064131342.USD","LU0320765992.SGD","LU0106261372.USD","LU2417539215.USD","LU2756315664.SGD","IE00B2B36J28.USD","LU0256863811.USD","LU0133085943.USD","LU0708995401.HKD","LU1069344957.HKD","IE00BJJMRY28.SGD","LU0787776722.HKD","LU2237443465.HKD","LU0689472784.USD","BK4532","IE00BJT1NW94.SGD","LLYZ","LU1093756168.USD","LU1629891620.HKD","SG9999015945.SGD","LLII","LU0198837287.USD","LU0432979614.USD","LU1023059063.AUD","IE00BK4W5L77.USD","LU2491050154.USD","LU0345770993.USD","LU0061475181.USD","LU0882574139.USD","SG9999014906.USD","LU0203201768.USD","LU1280957306.USD","IE00BWXC8680.SGD","LU1551013342.USD","LU0289739699.SGD","LU1623119135.USD","LU0323591593.USD","LU2023250330.USD","LU2237443978.SGD","LU2357305700.SGD","LU2237443895.HKD","LU0672654240.SGD","LU0385154629.USD","LU1814569148.SGD","SGXZ81514606.USD","BK4533","LU0096364046.USD","BK4534","LU1868837136.USD","LU0820561818.USD","LU0417517546.SGD","LU0471298777.SGD","LU0058720904.USD","LU0882574055.USD","LU0964807845.USD","LU2089284900.SGD","BK4516","LU0320765059.SGD","IE00BKDWB100.SGD","LU0353189763.USD","LU2028103732.USD","LU2087625088.SGD","LU2089984988.USD","LU2211815571.USD","LU2471134879.HKD","LU2602419157.SGD","BK4588","LLYX","LU1712237335.SGD","LU2237443622.USD","LU0122379950.USD","BK4007","LU2361044865.SGD","IE00BN29S564.USD","SG9999017495.SGD","LU2237443382.USD","IE00BFTCPJ56.SGD","IE00BJJMRX11.SGD","LU1145028129.USD","LU1868837300.USD","SG9999013999.USD","IE00BK4W5M84.HKD","LU2237438978.USD","SG9999015978.USD","LU0345770308.USD","LU1232071149.USD","LU0823434583.USD","SGXZ31699556.SGD","NVO","IE00BKPKM429.USD","LU1093756325.SGD","LU2264538146.SGD","LU1804176565.USD","NVOH","LU2063271972.USD","LU0786609619.USD","LU0943347566.SGD","LU2756315318.SGD","LU2468319806.SGD","LU2552382215.SGD","LU0683600562.USD","LU1868836591.USD","LU2360106947.USD","LU2746668974.SGD","SG9999001176.SGD","LU2213496289.HKD","LU2324357040.USD","LU2361044949.HKD","LU2471134952.CNY","LU1035775433.USD","SG9999014880.SGD","LU1291159041.SGD","IE00B7KXQ091.USD","IE00BJLML261.HKD","LU0820561909.HKD","LU2271345857.HKD","LU0109391861.USD","IE00BJJMRZ35.SGD","LU0210536198.USD","LU0471298694.HKD","LU1267930730.SGD","LU0225283273.USD","LU2108987350.USD","LU2750360641.GBP","LU1988902786.USD","IE00BFSS7M15.SGD","LU2236285917.USD","IE0002141913.USD","LU2896262040.SGD","LU2237443549.SGD","SG9999015952.SGD","LU0820562030.AUD","BK4585","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648383525","title":"Moderately bullish activity in Novo Nordisk with shares up 1.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648383525","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648383525?lang=en_us&edition=fundamental","pubTime":"2026-07-02 03:25","pubTimestamp":1782933913,"startTime":"0","endTime":"0","summary":"Moderately bullish activity in Novo Nordisk (NVO), with shares up 72c, or 1.51%, near $48.66. Options volume roughly in line with average with 56k ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-novo-nordisk-with-shares-up-1-51-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-novo-nordisk-with-shares-up-1-51-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVOH","BK4599","IE00BKVL7J92.USD","BK4532","LU1093756168.USD","IE00BZ1G4Q59.USD","LU0154236417.USD","NVO","NVOX","BK4585","LU1093756325.SGD","BK4588","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648422835","title":"Novo Nordisk A/S Stock Rises Wednesday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2648422835","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648422835?lang=en_us&edition=fundamental","pubTime":"2026-07-02 00:02","pubTimestamp":1782921720,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S rose 3.0% to DKK324.00 Wednesday on what proved to be an overall mediocre trading session for the stock market, with the OMX Nordic 40 Index holding steady at 2,703.93.The stock's rise  snapped a two-day losing streak.The company closed DKK140.60 below its 52-week high of DKK464.60, which the company reached on July 28, 2025.Trading volume was 4,419,979, compared to the 50-day average trading volume of 5,769,295.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 01, 2026 12:02 ET Copyright  2026 Dow Jones & Company, Inc.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOH","IE00BKVL7J92.USD","NVO","NVOX","IE00BZ1G4Q59.USD","BK4585","LU1093756168.USD","LU1093756325.SGD","LU0154236417.USD","BK4599","BK4532","BK4588","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648449415","title":"European Equities Traded in the US as American Depositary Receipts Fall Sharply in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2648449415","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648449415?lang=en_us&edition=fundamental","pubTime":"2026-07-01 23:12","pubTimestamp":1782918724,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking sharply lower late Wednesday morning, falling 1.61% to 1,890.71 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by internet advertising firm Criteo  and biotech company Evaxion , which rose 3% and 2.9% respectively. They were followed by pharmaceutical company Novo Nordisk  and software firm SAP , which were up 2.6% and 2.4% respectively.The decliners from continental Europe were led by telecommunications company Ericsson  and pharmaceutical company Sanofi , which lost 2.6% and 2.3% respectively. They were followed by oil and gas company Eni  and brewing company Anheuser-Busch InBev , which fell 2.2% and 1.3% respectively.The gainers from the UK were led by software firm Endava  and biopharmaceutical company NuCana , which advanced 5.7% and 3.3% respectively. They were followed by insurance company Prudential  and educational publisher Pearson , which increased 2.6% and 2.1","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BFXG1179.USD","BK4204","EVAX","LU2237443382.USD","BK4201","IHG","LU2456880835.USD","LU0128525929.USD","LU2237443895.HKD","BK4599","BDRX","NVO","BK4142","LU0058720904.USD","LU2237443465.HKD","NCNA","LU2468319806.SGD","LU1829250122.USD","IE00BZ1G4Q59.USD","BK4158","LU0029864427.USD","LU2236285917.USD","BUD","BK4020","LU0432979614.USD","BK4134","LU0084288595.USD","LU2462157665.USD","BK4588","LU1267930573.SGD","SNY","BK4162","BK4585","BK4111","IE00B3T34201.USD","IE00BFMHRM44.USD","BK4528","AZNH","LU0648005311.SGD","BK4515","BK4532","LU0708994859.HKD","LU2237443622.USD","BK4139","IE00BKVL7J92.USD","SAP","NVOH","BK4554","LU0109394709.USD","PUK","LU0320765992.SGD","LU2417539215.USD","LU2089984988.USD","PSO","LU2237443549.SGD","DAVA","BK4023","NVOX","LU1093756168.USD","E","TRIB","BK4591","AZN","BK4009","BK4568","CRTO","LU0289739699.SGD","LU2237443978.SGD","BK4082","LU0889565916.HKD","ERIC","LU0154236417.USD","LU1093756325.SGD","BK4007","02378","LU0310800379.SGD","BK4613"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648516229","title":"The Latest Senior-citizen Special is Here: Cheap Weight-loss Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2648516229","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648516229?lang=en_us&edition=fundamental","pubTime":"2026-07-01 17:00","pubTimestamp":1782896400,"startTime":"0","endTime":"0","summary":"Millions of older Americans are on the cusp of more affordable access to popular weight-loss drugs when a major Medicare coverage expansion kicks in July 1.Medicare will pilot a program, dubbed Bridge","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989771016.USD","LU0210536198.USD","IE0004445015.USD","LU0640476718.USD","LU2023250330.USD","LU0198837287.USD","LU0320765992.SGD","IE00B4R5TH58.HKD","LU0266013472.USD","BK4588","LU2023250504.SGD","LU2491050154.USD","LU1814569148.SGD","LU2236285917.USD","IE00BN29S564.USD","IE00BJJMRY28.SGD","IE00BJJMRZ35.SGD","BK4532","LU0122379950.USD","LU1988902786.USD","SG9999001176.SGD","LLYZ","LU0006306889.USD","LU1035775433.USD","LU0456855351.SGD","IE00BJT1NW94.SGD","IE00BJJMRX11.SGD","LU2552382058.USD","IE0009355771.USD","LU1323610961.USD","LU0109391861.USD","BK4534","LU2324357040.USD","LU2361045086.USD","BK4581","LU2023251221.USD","LU2168564065.EUR","LU0787776722.HKD","LU0466842654.USD","LU0882574139.USD","IE00BKVL7J92.USD","LU0256863902.USD","SG9999018865.SGD","SGXZ51526630.SGD","LU2896262040.SGD","LU1061106388.HKD","SG9999014880.SGD","IE00B1BXHZ80.USD","LU0786609619.USD","LU0354030511.USD","LU1868837136.USD","LU2491049909.HKD","IE00B2B36J28.USD","LU2271345857.HKD","LU2168564149.EUR","NVOH","IE0005OL40V9.USD","LLII","LU2750360641.GBP","LU2602419157.SGD","LU2237443465.HKD","LU2087625088.SGD","LU0823434583.USD","IE00BWXC8680.SGD","LU2357305700.SGD","LU2237443382.USD","LU1057294990.SGD","LU1551013425.SGD","LU2237443622.USD","LU2462157665.USD","LU0672654240.SGD","LU2211815571.USD","LU1064131342.USD","IE00BJLML261.HKD","LU0289739699.SGD","LU2213496289.HKD","IE00B1XK9C88.USD","LU1983299246.USD","LU1868837300.USD","NVOX","LU0820561909.HKD","LU1093756325.SGD","LU0889565916.HKD","LU0385154629.USD","IE00BFSS7M15.SGD","LU0097036916.USD","LU0238689110.USD","BK4007","LU1551013342.USD","IE0004445239.USD","IE00BFTCPJ56.SGD","LU2750360997.AUD","LU2112291526.USD","IE00BZ1G4Q59.USD","LU2168564495.EUR","LU1232071149.USD","LU2089284900.SGD","LLYX","LU0320765059.SGD","LU2089984988.USD","BK4585","LU2111349929.HKD","LU0353189763.USD","LU2089283258.USD","LU2468319806.SGD","SGXZ81514606.USD","LU0689472784.USD","SG9999014914.USD","LU0820562030.AUD","SGXZ31699556.SGD","IE00B7KXQ091.USD","IE00B775H168.HKD","LU1280957306.USD","LU2168563687.JPY","LU1366192091.USD","LU0417517546.SGD","LU0353189680.USD","LU1291159041.SGD","SG9999018857.SGD","LU2471134952.CNY","LU2265009873.SGD","LU2746668974.SGD","ELIL","LU1974910355.USD","SG9999014898.SGD","GB00BDT5M118.USD","LU0823434740.USD","LU2756315664.SGD","LU0823416689.USD","BK4599","BK4516","LU1623119135.USD","LU0432979614.USD","LU0061475181.USD","LU2237438978.USD","IE00BK4W5L77.USD","SG9999015952.SGD","LU0109394709.USD","LU0471298777.SGD","IE0002141913.USD","SG9999015986.USD","LU1868836591.USD","LU0820561818.USD","IE00BKPKM429.USD","LU1868836914.USD","LU1267930730.SGD","LU2108987350.USD","LU0094547139.USD","LU2237443978.SGD","SG9999013999.USD","SG9999017495.SGD","LU1023059063.AUD","LU0354030438.USD","IE00BKDWB100.SGD","LU1127390331.HKD","LU2237443549.SGD","LU0683600562.USD","IE0001KFT4U8.USD","IE00BK4W5M84.HKD","LU0096364046.USD","LU1093756168.USD","LU2106854487.HKD","LU1548497426.USD","LU1712237335.SGD","LU2417539215.USD","LU2552382132.HKD","LU0316494557.USD","SGXZ99366536.SGD","LU0158827948.USD","LU0471298694.HKD","LU2168564222.USD","LU0203201768.USD","LU0256863811.USD","LU2552382215.SGD","LU2360106947.USD","LLY","LU1145028129.USD","LU0114720955.EUR","SGXZ57979304.SGD","LU0225283273.USD","LU2361044949.HKD","NVO","LU2264538146.SGD","LU1804176565.USD","LU1868836757.USD","LU0323591593.USD","LU2237443895.HKD","LU2461242641.AUD","LU2063271972.USD","LU2361044865.SGD","LU1069344957.HKD","BK4533","LU0203202063.USD","IE00B4JS1V06.HKD","LU0882574055.USD","IE00BFSS8Q28.SGD","LU0154236417.USD","LU2756315318.SGD","LU0708995401.HKD","LU2491050071.SGD","LU0058720904.USD","LU2471134523.USD","LU2471134796.USD","LU2746668461.USD","LU0964807845.USD","SG9999014906.USD","LU2028103732.USD","LU2471134879.HKD","SG9999001176.USD","LU0079474960.USD","LU2456880835.USD","LU0234572021.USD","LU0943347566.SGD","LU1629891620.HKD","LU1720051108.HKD","LU1720051017.SGD","SG9999015945.SGD","LU0106261372.USD","LU0158827781.USD","LU1917777945.USD","LU0133085943.USD","ELIS","SG9999015978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648551398","title":"Novo Holdings CEO Says Commitment to Planetary Health Investing Remains Steadfast","url":"https://stock-news.laohu8.com/highlight/detail?id=2648551398","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648551398?lang=en_us&edition=fundamental","pubTime":"2026-07-01 15:45","pubTimestamp":1782891955,"startTime":"0","endTime":"0","summary":"Novo Holdings CEO says commitment to planetary health investing remains steadfastNovo Holdings management reaffirmed its long-term commitment to responsible investing, with sustained focus on planetar","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nNDLbKDvy6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4532","LU1093756325.SGD","LU1093756168.USD","BK4588","BK4585","NVOH","NVOX","IE00BZ1G4Q59.USD","BK4599","IE00BKVL7J92.USD","NVO","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648561263","title":"Medicare GLP-1 Bridge Program Will Pay for Novo, Lilly Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2648561263","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648561263?lang=en_us&edition=fundamental","pubTime":"2026-07-01 04:03","pubTimestamp":1782849780,"startTime":"0","endTime":"0","summary":"The federal Medicare agency is expanding access to weight loss drugs under a new temporary program starting Wednesday. Millions of people may be eligible for medication, but it may not lead to an imme","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","IE00BJJMRY28.SGD","LU0689472784.USD","LU0820561909.HKD","LU2237438978.USD","LU2237443465.HKD","SG9999014898.SGD","LU2023250330.USD","LU2456880835.USD","LU1093756325.SGD","LU0203201768.USD","LU0320765992.SGD","SGXZ81514606.USD","LU2168564495.EUR","LU2237443978.SGD","IE0004445239.USD","LU2471134879.HKD","LU2168563687.JPY","NVOX","BK4585","LU0158827948.USD","LU1323610961.USD","LU1093756168.USD","BK4007","LU0820562030.AUD","LU1983299246.USD","LU1232071149.USD","LU1267930730.SGD","LU2756315318.SGD","LU0787776722.HKD","BK4581","IE00B1BXHZ80.USD","SGXZ99366536.SGD","LU2471134952.CNY","IE00BJLML261.HKD","LU0210536198.USD","LU2491050154.USD","LU2471134523.USD","LU0417517546.SGD","LU0122379950.USD","LU1868837136.USD","NVO","IE00B1XK9C88.USD","LU0256863902.USD","LU0097036916.USD","LU0289739699.SGD","SG9999013999.USD","LU2168564149.EUR","LU1551013342.USD","LU1064131342.USD","LU2211815571.USD","BK4534","LU0466842654.USD","IE0002141913.USD","LU0353189680.USD","BK4516","LU0708995401.HKD","IE00B4R5TH58.HKD","LU2756315664.SGD","IE00BK4W5M84.HKD","LU0964807845.USD","LU0106261372.USD","BK4588","LU0006306889.USD","LU1629891620.HKD","LU2111349929.HKD","LU2491050071.SGD","LU0353189763.USD","LLII","SG9999015978.USD","LU2324357040.USD","LU0154236417.USD","LU2552382132.HKD","BK4532","LU0471298777.SGD","LU0109391861.USD","LU2602419157.SGD","LU2746668461.USD","ELIS","LU0683600562.USD","LU0133085943.USD","LU1804176565.USD","LU2237443549.SGD","LLYX","LU0234572021.USD","LLY","LU2213496289.HKD","SGXZ57979304.SGD","LU1127390331.HKD","LU1551013425.SGD","LU0786609619.USD","IE00BFTCPJ56.SGD","IE00B7KXQ091.USD","LU0432979614.USD","IE0001KFT4U8.USD","LU0320765059.SGD","LU1366192091.USD","LU2264538146.SGD","LU0882574139.USD","LU2089984988.USD","LU1868837300.USD","NVOH","LU0943347566.SGD","LU1989771016.USD","IE0005OL40V9.USD","LU0823434583.USD","LU2168564065.EUR","LU1291159041.SGD","LU2750360641.GBP","LU1023059063.AUD","LU0354030438.USD","LU2360106947.USD","IE00BJT1NW94.SGD","LU0672654240.SGD","SG9999018857.SGD","LU1720051108.HKD","LU0471298694.HKD","LU0823416689.USD","LU1720051017.SGD","LU1868836757.USD","LU0158827781.USD","LU0094547139.USD","LU0203202063.USD","LU1974910355.USD","SGXZ31699556.SGD","IE00BKVL7J92.USD","SG9999014914.USD","IE00B775H168.HKD","LU1868836914.USD","IE00BZ1G4Q59.USD","LU2361044949.HKD","LU2552382215.SGD","LU1145028129.USD","IE00B4JS1V06.HKD","LU2108987350.USD","SG9999014906.USD","LU0820561818.USD","LU1057294990.SGD","LU0114720955.EUR","LU2271345857.HKD","LU0456855351.SGD","LU2112291526.USD","IE00B2B36J28.USD","LU2237443622.USD","LU0823434740.USD","LU2750360997.AUD","IE00BK4W5L77.USD","LU0323591593.USD","LU2462157665.USD","LU2023250504.SGD","LU0316494557.USD","ELIL","LLYZ","LU0225283273.USD","LU1069344957.HKD","LU1548497426.USD","IE00BFSS7M15.SGD","BK4533","LU0640476718.USD","LU2023251221.USD","SG9999001176.USD","IE00BJJMRZ35.SGD","LU0256863811.USD","SG9999015945.SGD","SG9999017495.SGD","LU0266013472.USD","IE00BJJMRX11.SGD","LU2471134796.USD","BK4599","LU2237443895.HKD","IE0009355771.USD","LU0096364046.USD","IE00BFSS8Q28.SGD","LU2746668974.SGD","LU0198837287.USD","LU2089284900.SGD","LU2106854487.HKD","LU0354030511.USD","LU2236285917.USD","LU0238689110.USD","LU2028103732.USD","LU2357305700.SGD","LU2896262040.SGD","SGXZ51526630.SGD","SG9999015986.USD","LU2237443382.USD","SG9999001176.SGD","LU1917777945.USD","GB00BDT5M118.USD","IE00BWXC8680.SGD","LU2063271972.USD","SG9999014880.SGD","LU2461242641.AUD","LU2361044865.SGD","LU0109394709.USD","LU0079474960.USD","LU2417539215.USD","SG9999018865.SGD","LU0882574055.USD","LU2491049909.HKD","LU2265009873.SGD","LU1712237335.SGD","LU1280957306.USD","IE00BN29S564.USD","LU2468319806.SGD","LU0061475181.USD","LU1061106388.HKD","LU1814569148.SGD","LU0385154629.USD","LU1623119135.USD","LU2168564222.USD","LU1988902786.USD","LU0889565916.HKD","LU2087625088.SGD","LU2552382058.USD","LU2089283258.USD","LU1035775433.USD","LU0058720904.USD","LU2361045086.USD","IE0004445015.USD","IE00BKDWB100.SGD","SG9999015952.SGD","LU1868836591.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648566478","title":"Millions of Americans Can Get Medicare to Cover Glp-1s for Weight Loss Starting This Week. Here's How Much it Costs.","url":"https://stock-news.laohu8.com/highlight/detail?id=2648566478","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648566478?lang=en_us&edition=fundamental","pubTime":"2026-07-01 02:44","pubTimestamp":1782845040,"startTime":"0","endTime":"0","summary":"Older Americans previously could only access GLP-1 coverage for diabetes or cardiovascular disease through Medicare. See if you qualify now.Some Medicare patients will soon have access to GLP-1 drugs ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELIL","LU0353189680.USD","LU2237443622.USD","LU0820561909.HKD","IE00BWXC8680.SGD","SG9999001176.USD","LU0109391861.USD","LU0198837287.USD","LU0323591593.USD","LU0079474960.USD","NVO","ELIS","BK4532","LU2111349929.HKD","IE00BKVL7J92.USD","LU2468319806.SGD","LU0316494557.USD","LU2491050154.USD","LU0097036916.USD","BK4588","LU2756315664.SGD","LU0471298694.HKD","GB00BDT5M118.USD","IE0004445015.USD","IE00B4R5TH58.HKD","LU0640476718.USD","IE00BK4W5L77.USD","LU1868836914.USD","IE00B2B36J28.USD","IE00BFSS7M15.SGD","LU1061106388.HKD","LU2237443465.HKD","LU0058720904.USD","BK4007","IE00B4JS1V06.HKD","LU1988902786.USD","LU0466842654.USD","LU2462157665.USD","LU2552382132.HKD","LU2112291526.USD","SG9999018865.SGD","LU0672654240.SGD","LU2237443895.HKD","IE00BKPKM429.USD","LU0289739699.SGD","LU0158827948.USD","LU1551013425.SGD","SGXZ51526630.SGD","LU2168564065.EUR","LU0210536198.USD","LU2552382215.SGD","IE00BJLML261.HKD","LU0094547139.USD","SG9999014898.SGD","LU2602419157.SGD","LU0256863902.USD","IE0009355771.USD","LU2461242641.AUD","LU2471134952.CNY","LU2023250330.USD","LU1804176565.USD","LU0320765059.SGD","LU2750360997.AUD","BK4534","IE00BJJMRY28.SGD","LU1035775433.USD","LU2023251221.USD","LU0109394709.USD","LU2471134796.USD","LU1232071149.USD","SG9999015978.USD","LU2063271972.USD","LU2746668974.SGD","LU0266013472.USD","LU0353189763.USD","LU0823416689.USD","LU0154236417.USD","LU0385154629.USD","LU0225283273.USD","LU2265009873.SGD","LU2552382058.USD","LU0203201768.USD","LU2028103732.USD","NVOX","SGXZ57979304.SGD","SG9999013999.USD","IE00BFTCPJ56.SGD","IE00BZ1G4Q59.USD","LU1989771016.USD","LU0238689110.USD","LU0823434583.USD","LU1023059063.AUD","NVOH","LU1127390331.HKD","LU2491049909.HKD","LU2750360641.GBP","IE00B1XK9C88.USD","IE0004445239.USD","LLY","LU0889565916.HKD","LU1868837136.USD","LU1323610961.USD","LU1720051017.SGD","LU2168563687.JPY","LU2324357040.USD","LU2023250504.SGD","LU2896262040.SGD","SG9999015986.USD","LU0006306889.USD","SGXZ31699556.SGD","LU1720051108.HKD","IE00BK4W5M84.HKD","LU2237443549.SGD","LU0320765992.SGD","LU2106854487.HKD","LU1057294990.SGD","BK4599","IE00B1BXHZ80.USD","LU2360106947.USD","LU0106261372.USD","LU1868837300.USD","BK4585","LU0823434740.USD","LU2213496289.HKD","LU2236285917.USD","LU1291159041.SGD","LU0471298777.SGD","LU2491050071.SGD","LU2746668461.USD","LU0820561818.USD","IE0005OL40V9.USD","LU2237443978.SGD","LU2361044865.SGD","LU0256863811.USD","LU2264538146.SGD","LU0432979614.USD","LU1814569148.SGD","LU1917777945.USD","IE00BFSS8Q28.SGD","LLYX","LU0203202063.USD","LU0882574055.USD","LU1064131342.USD","LU0787776722.HKD","LU0061475181.USD","LU2089283258.USD","LU1623119135.USD","LU2361045086.USD","SG9999014914.USD","LU0683600562.USD","LU2211815571.USD","SG9999017495.SGD","LU0096364046.USD","LU0133085943.USD","LU0158827781.USD","LU1093756168.USD","LU0114720955.EUR","LU0820562030.AUD","LU0354030438.USD","SG9999001176.SGD","LU0708995401.HKD","LU2168564222.USD","LU2471134523.USD","LU2471134879.HKD","IE0002141913.USD","LU2087625088.SGD","SG9999018857.SGD","LU2756315318.SGD","SG9999015945.SGD","LU2271345857.HKD","IE00BN29S564.USD","LU1093756325.SGD","LU1983299246.USD","SG9999015952.SGD","LU1868836757.USD","LU2237438978.USD","LU2237443382.USD","LU1974910355.USD","LU2108987350.USD","LU2168564149.EUR","LU0354030511.USD","LU0689472784.USD","LU2089984988.USD","LU0234572021.USD","LU0943347566.SGD","LU1145028129.USD","LU2361044949.HKD","LU1280957306.USD","LU1629891620.HKD","SGXZ99366536.SGD","IE0001KFT4U8.USD","LU1548497426.USD","LU2168564495.EUR","LU1551013342.USD","LU0417517546.SGD","BK4533","LU0882574139.USD","LU1069344957.HKD","LU2357305700.SGD","IE00BJT1NW94.SGD","LU0786609619.USD","LLII","LU2089284900.SGD","BK4581","SG9999014880.SGD","IE00B775H168.HKD","LU0964807845.USD","IE00BJJMRZ35.SGD","LU1267930730.SGD","LU1868836591.USD","IE00B7KXQ091.USD","IE00BKDWB100.SGD","IE00BJJMRX11.SGD","LU1712237335.SGD","SGXZ81514606.USD","LU0122379950.USD","LLYZ","LU2417539215.USD","BK4516","LU2456880835.USD","LU1366192091.USD","SG9999014906.USD","LU0456855351.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135251165","title":"US Medicare to Cover Weight-Loss Drugs for the First Time from July, Boosting Novo Nordisk Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1135251165","media":"Deep News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135251165?lang=en_us&edition=fundamental","pubTime":"2026-06-30 20:32","pubTimestamp":1782822737,"startTime":"0","endTime":"0","summary":"US Medicare announced on Monday that it will, for the first time, begin covering selective GLP-1 class weight-loss drugs starting July 1, including the injectable semaglutide produced by Novo Nordisk...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0795875169.SGD","LU2271345857.HKD","NVOX","BK4504","LU1093756168.USD","LU1244550577.SGD","LU0314104364.USD","LU0882574139.USD","LU0006306889.USD","LU0098860793.USD","LU1720051017.SGD","BK4516","LU2487616109.SGD","LU1791710582.SGD","LU0795875086.SGD","BK4532","NVO","LU1791710400.SGD","BK4007","MS","LU0267386448.USD","LU0106831901.USD","LU1548497426.USD","LU0971096721.USD","LU2347655156.SGD","LU0154236417.USD","LU0158827948.USD","LU2357305700.SGD","NVOH","LU0528227936.USD","BK4588","LU1989772840.SGD","BK4127","LU1668664300.SGD","LU2089283258.USD","BK4534","LU1720051108.HKD","LU0912757837.SGD","LU2023251221.USD","LU1064131342.USD","LU0390134368.USD","LU0210528500.USD","LU1732800096.USD","LU0158827781.USD","LU0225283273.USD","LU0557290698.USD","LU0053666078.USD","LU2111349929.HKD","LU2133065610.SGD","LU0320765646.SGD","LU1162221912.USD","LU0234570918.USD","LU1093756325.SGD","LU1988902786.USD","LU2089284900.SGD","LU1244550221.USD","LU1732799900.SGD","BK4581","BK4585","BK4599","LU1074936037.SGD","LU1363072403.SGD","LU1989772923.USD","LU1244550494.USD","LU0106261372.USD","LU2028103732.USD","LU2264538146.SGD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647582935","title":"Jefferies Sticks to Their Hold Rating for Novo Nordisk (0QIU)","url":"https://stock-news.laohu8.com/highlight/detail?id=2647582935","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647582935?lang=en_us&edition=fundamental","pubTime":"2026-06-30 13:25","pubTimestamp":1782797115,"startTime":"0","endTime":"0","summary":"In a report released today, Michael Leuchten from Jefferies maintained a Hold rating on Novo Nordisk, with a price target of DKK285.00. According t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jefferies-sticks-to-their-hold-rating-for-novo-nordisk-0qiu-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jefferies-sticks-to-their-hold-rating-for-novo-nordisk-0qiu-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","BK4585","NVOH","BK4532","BK4599","LU0154236417.USD","LU1093756325.SGD","BK4007","NVOX","LU1093756168.USD","NVO","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647071953","title":"Canada Approves Apotex's Bid to Sell Generic Version of Wegovy","url":"https://stock-news.laohu8.com/highlight/detail?id=2647071953","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647071953?lang=en_us&edition=fundamental","pubTime":"2026-06-30 05:34","pubTimestamp":1782768840,"startTime":"0","endTime":"0","summary":"OTTAWA--Canadian regulators approved Apotex's bid to manufacture a generic version of the weight-loss drug Wegovy.Canada's health department, which is in charge of drug approvals, said Monday it autho","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ1G4Q59.USD","BK4585","LU1093756325.SGD","BK4588","LU0154236417.USD","NVOH","LU1093756168.USD","NVO","NVOX","BK4532","BK4599","BK4007","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647302750","title":"Novo Nordisk Accelerates Share Buybacks Under DKK 15 Billion Programme","url":"https://stock-news.laohu8.com/highlight/detail?id=2647302750","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647302750?lang=en_us&edition=fundamental","pubTime":"2026-06-30 04:48","pubTimestamp":1782766105,"startTime":"0","endTime":"0","summary":"Novo Nordisk ( ($NVO) ) has shared an update. On 6 May 2026, Novo Nordisk launched a share repurchase programme under EU Safe Harbour rules as part...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-accelerates-share-buybacks-under-dkk-15-billion-programme?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-accelerates-share-buybacks-under-dkk-15-billion-programme?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0154236417.USD","LU1093756325.SGD","NVOH","NVOX","BK4588","LU1093756168.USD","BK4532","BK4599","BK4585","NVO","BK4007","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647055523","title":"Novo Nordisk A/S Stock Falls Monday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2647055523","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647055523?lang=en_us&edition=fundamental","pubTime":"2026-06-30 00:02","pubTimestamp":1782748920,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S dropped 1.0% to DKK314.90 Monday on what proved to be an overall positive trading session for the stock market, with the OMX Nordic 40 Index rising 0.1% to 2,666.06.The stock's fall  snapped a six-day winning streak.The company closed DKK149.70 below its 52-week high of DKK464.60, which the company achieved on July 28, 2025.Trading volume was 3,206,174, compared to the 50-day average trading volume of 5,866,378.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJune 29, 2026 12:02 ET Copyright  2026 Dow Jones & Company, Inc.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","BK4532","NVOH","IE00BZ1G4Q59.USD","LU1093756168.USD","BK4007","NVO","NVOX","IE00BKVL7J92.USD","LU0154236417.USD","LU1093756325.SGD","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647327726","title":"FDA Set to Review Sandoz's Generic Glp-1s","url":"https://stock-news.laohu8.com/highlight/detail?id=2647327726","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647327726?lang=en_us&edition=fundamental","pubTime":"2026-06-29 17:30","pubTimestamp":1782725420,"startTime":"0","endTime":"0","summary":"FDA set to review Sandoz's generic GLP-1sZURICH, June 29 (Reuters)-The U.S. Food and Drug Administration has agreed to review Swiss generics drugmaker Sandoz'sSDZ.Stwo generic tirzepatide GLP-1s that,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nL8N4310CZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BK4W5L77.USD","LU0640476718.USD","LU0234572021.USD","SG9999014914.USD","LU2106854487.HKD","IE00BFSS7M15.SGD","LU1023059063.AUD","LU0354030438.USD","LLY","LU0471298694.HKD","SGXZ31699556.SGD","LU0683600562.USD","LU2168564222.USD","LU2462157665.USD","LU2168564149.EUR","LU0266013472.USD","LU1868836914.USD","LU1623119135.USD","LU0256863811.USD","LU2361044865.SGD","LU0882574055.USD","LU1064131342.USD","LU1989771016.USD","LU0097036916.USD","LU2750360641.GBP","LU0158827781.USD","LU0061475181.USD","LLII","LU2237443549.SGD","IE00BKPKM429.USD","LU0456855351.SGD","IE0004445015.USD","LU1551013425.SGD","LU0210536198.USD","LU0289739699.SGD","LU2896262040.SGD","LU0823434583.USD","LU0158827948.USD","LU2468319806.SGD","IE00B4JS1V06.HKD","LU2360106947.USD","LU0094547139.USD","LU0689472784.USD","LU2089284900.SGD","IE00B7KXQ091.USD","LU1145028129.USD","LU2023251221.USD","LU2756315318.SGD","IE00BJJMRX11.SGD","LU0964807845.USD","SGXZ51526630.SGD","LU1868836591.USD","LU2491050154.USD","LU2237443895.HKD","SGXZ99366536.SGD","LU1035775433.USD","LU2168564495.EUR","LU2361044949.HKD","LU2456880835.USD","LU2746668461.USD","LU2108987350.USD","SG9999014906.USD","LU1629891620.HKD","BK4581","LU0114720955.EUR","LU0203201768.USD","LU1232071149.USD","LU1983299246.USD","IE00B1XK9C88.USD","LU1323610961.USD","SG9999015986.USD","LU0225283273.USD","LU2361045086.USD","LU0198837287.USD","BK4588","IE0004445239.USD","LU0203202063.USD","LU2237443465.HKD","LU2264538146.SGD","BK4532","LU1720051017.SGD","SG9999001176.SGD","LU2552382058.USD","LU0820562030.AUD","LU1267930730.SGD","LU1720051108.HKD","BK4533","LU2211815571.USD","SG9999018857.SGD","LU0823416689.USD","LU0385154629.USD","LU0354030511.USD","LU2089283258.USD","LU0672654240.SGD","LU2471134523.USD","LU0471298777.SGD","LU0133085943.USD","LU2417539215.USD","NVOH","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","ELIL","LU1712237335.SGD","LU1069344957.HKD","SG9999001176.USD","SG9999014880.SGD","LU2237443978.SGD","SG9999013999.USD","SG9999015952.SGD","LU0079474960.USD","IE00BJJMRZ35.SGD","LU2750360997.AUD","LU2746668974.SGD","LU2265009873.SGD","SDZXF","LU2461242641.AUD","LU1280957306.USD","LLYZ","LU0820561909.HKD","LU0943347566.SGD","LU0882574139.USD","LU1814569148.SGD","BK4007","LU1057294990.SGD","IE00B1BXHZ80.USD","LU2602419157.SGD","BK4516","LU0320765992.SGD","IE00B2B36J28.USD","LU0106261372.USD","NVOX","LU0122379950.USD","IE00BWXC8680.SGD","LU0432979614.USD","LU1291159041.SGD","LU2237443622.USD","LU0786609619.USD","LU1551013342.USD","IE0005OL40V9.USD","BK4599","LU1127390331.HKD","IE00BK4W5M84.HKD","LU2089984988.USD","LU2324357040.USD","LU0353189680.USD","ELIS","LU1917777945.USD","LU0006306889.USD","IE00BFTCPJ56.SGD","LU0154236417.USD","SG9999014898.SGD","SG9999015978.USD","IE00BN29S564.USD","LU2028103732.USD","IE0001KFT4U8.USD","LU0417517546.SGD","LU1548497426.USD","IE00BJJMRY28.SGD","LU1868837300.USD","LU2168563687.JPY","LU2213496289.HKD","IE00BJT1NW94.SGD","LU2236285917.USD","LU2271345857.HKD","LU1093756168.USD","LU2471134796.USD","LU2087625088.SGD","GB00BDT5M118.USD","LU0820561818.USD","IE00BKDWB100.SGD","IE00BFSS8Q28.SGD","LU2063271972.USD","LU2112291526.USD","SG9999018865.SGD","BK4534","LU0238689110.USD","LU0323591593.USD","LU0787776722.HKD","LU1061106388.HKD","LU1093756325.SGD","LU2357305700.SGD","LLYX","LU2237443382.USD","SG9999017495.SGD","LU0109391861.USD","IE0009355771.USD","LU2756315664.SGD","LU0320765059.SGD","IE00BJLML261.HKD","LU0256863902.USD","LU2471134952.CNY","SGXZ81514606.USD","LU2552382215.SGD","LU2168564065.EUR","LU2552382132.HKD","LU1804176565.USD","LU0316494557.USD","LU2471134879.HKD","IE00B4R5TH58.HKD","LU1366192091.USD","SGXZ57979304.SGD","LU0889565916.HKD","LU0823434740.USD","LU0353189763.USD","LU0466842654.USD","LU0096364046.USD","LU1974910355.USD","LU1868836757.USD","LU0708995401.HKD","NVO","SG9999015945.SGD","LU0058720904.USD","LU0109394709.USD","LU2491050071.SGD","LU1988902786.USD","LU1868837136.USD","LU2023250330.USD","IE0002141913.USD","BK4585","LU2111349929.HKD","IE00B775H168.HKD","LU2491049909.HKD","LU2237438978.USD","LU2023250504.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647321881","title":"Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO) and Sanofi (SNY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2647321881","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647321881?lang=en_us&edition=fundamental","pubTime":"2026-06-29 15:40","pubTimestamp":1782718838,"startTime":"0","endTime":"0","summary":"Analysts fell to the sidelines weighing in on Novo Nordisk (NVO) and Sanofi (SNY) with neutral ratings, indicating that the experts are neither bul...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-novo-nordisk-nvo-and-sanofi-sny-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-novo-nordisk-nvo-and-sanofi-sny-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","LU1093756325.SGD","NVOH","NVO","BK4588","BK4599","LU1093756168.USD","IE00BFXG1179.USD","IE00BZ1G4Q59.USD","SNY","BK4007","BK4585","NVOX","LU0154236417.USD","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.1248},{"period":"1month","weight":0.3427},{"period":"3month","weight":0.7233},{"period":"6month","weight":-0.2319},{"period":"1year","weight":-0.6592},{"period":"ytd","weight":-0.1891}],"compareEarnings":[{"period":"1week","weight":0.0143},{"period":"1month","weight":-0.0195},{"period":"3month","weight":0.1356},{"period":"6month","weight":0.0902},{"period":"1year","weight":0.2004},{"period":"ytd","weight":0.0922}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"ARCA","name":"Defiance Daily Target 2X Long NVO ETF","nameEN":"Defiance Daily Target 2X Long NVO ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.1","shortVersion":"4.45.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Defiance Daily Target 2X Long NVO ETF(NVOX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Defiance Daily Target 2X Long NVO ETF(NVOX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Defiance Daily Target 2X Long NVO ETF,NVOX,Defiance Daily Target 2X Long NVO ETF股票,Defiance Daily Target 2X Long NVO ETF股票老虎,Defiance Daily Target 2X Long NVO ETF股票老虎国际,Defiance Daily Target 2X Long NVO ETF行情,Defiance Daily Target 2X Long NVO ETF股票行情,Defiance Daily Target 2X Long NVO ETF股价,Defiance Daily Target 2X Long NVO ETF股市,Defiance Daily Target 2X Long NVO ETF股票价格,Defiance Daily Target 2X Long NVO ETF股票交易,Defiance Daily Target 2X Long NVO ETF股票购买,Defiance Daily Target 2X Long NVO ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Defiance Daily Target 2X Long NVO ETF(NVOX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Defiance Daily Target 2X Long NVO ETF(NVOX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}